Living with Mild Cognitive Impairment (MCI)

HABIT Healthy Action to Benefit Independence & Thinking

Welcome to the HABIT page for people living with Mild Cognitive Impairment (MCI) and program participants.  The HABIT Program is for individuals with MCI and their loved ones to learn the best strategies for adapting, coping, and living their best lives with MCI.

Follow the HABIT page to receive updates and information about adjusting to MCI and combating dementia. Our goal is to connect you with others and provide you with information and support.

PUBLIC PAGE
Tue, Feb 20, 2018 10:12am

Have You Heard About the Latest News About Treating MCI? Here’s How to Evaluate It.

By Dr. Anne Shandera-Ochsner, HABIT MN Director, @dranneshanderaochsner

Man Looking In Microscope

The lack of available treatments for Mild Cognitive Impairment (MCI) is frustrating for patients, families, and providers. When a new study or possible treatment approach comes out, it often gets featured in the mainstream media, and it can be hard to remind yourself to hold your excitement until you know more about the quality of the evidence being presented. If you’re not a scientist or healthcare provider, this can feel easier said than done. However, you can weed out the bad apples and flimsy claims by doing a little extra digging.

Here are a few points to consider:

  1. How big was the study?
    • The article you see may not give an exact number, especially if it’s in the lay media (e.g., a magazine, internet, or newspaper article). But, you can look for clues such as the words “case study” or reference to one or two individuals to tip you off to the fact that this report is based on a very small number of people.
    • In general, the smaller the number of people in a study, the less you should trust that the results may apply to you. In research, the most convincing evidence comes from studies of big groups of people.
  2. Was the research independent and free of bias?
    • It’s important to know who is reporting the findings. Sometimes, supplements or cognitive training products (e.g., brain training) mention lots of research with impressive sounding findings. But, if you look carefully, you can see that the research has all been done by the company actually selling the product or supplement.
    • Along the same lines, be alert for flashy advertising and “research” claims that are part of an attempt to get you to spend money on something. Be especially careful about internet sites that want you to pay to find out about the latest way to prevent Alzheimer’s disease.
    • As a rule, supplements (vs prescription medications) are NOT evaluated or monitored by the FDA, and so companies can make strong claims that have not been proven.
  3. Have the findings been confirmed by another study?
    • The most convincing and compelling research findings have been “replicated” or reproduced by 2 or more independent groups of scientists. Showing the same result no matter who does the research is a great way to increase the likelihood that a finding is something to get excited about.
  4. What does your healthcare professional think?
    • If you’re really curious about a particular finding and think it might be worth trying out yourself, be sure to talk to your healthcare provider and get their opinion first. Healthcare professionals typically have access to research that is not available to the general public, and are in a good position to judge the quality of evidence. They can also be alert to any risks or side effects that might come from taking a supplement with your regular medications.

Learn more about how to be savvy about non-traditional treatments in this Mayo Clinic article https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/alternative-medicine/art-20046087

Chime in! How do you evaluate company or research claims? How do you guard against scams?
Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Living with Mild Cognitive Impairment (MCI) page.

We'll include this text in the user's invitation.